Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP721031.RAUOu7B58T7JZNpGRVhfwFKJ6VANPz6NTK17WMQ3M2ziA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP721031.RAUOu7B58T7JZNpGRVhfwFKJ6VANPz6NTK17WMQ3M2ziA130_assertion type Assertion NP721031.RAUOu7B58T7JZNpGRVhfwFKJ6VANPz6NTK17WMQ3M2ziA130_head.
- NP721031.RAUOu7B58T7JZNpGRVhfwFKJ6VANPz6NTK17WMQ3M2ziA130_assertion description "[We have characterized amyloid beta peptide (Abeta) concentration, Abeta deposition, paired helical filament formation, cerebrovascular amyloid angiopathy, apolipoprotein E (ApoE) allotype, and synaptophysin concentration in entorhinal cortex and superior frontal gyrus of normal elderly control (ND) patients, Alzheimer's disease (AD) patients, and high pathology control (HPC) patients who meet pathological criteria for AD but show no synapse loss or overt antemortem symptoms of dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721031.RAUOu7B58T7JZNpGRVhfwFKJ6VANPz6NTK17WMQ3M2ziA130_provenance.
- NP721031.RAUOu7B58T7JZNpGRVhfwFKJ6VANPz6NTK17WMQ3M2ziA130_assertion evidence source_evidence_literature NP721031.RAUOu7B58T7JZNpGRVhfwFKJ6VANPz6NTK17WMQ3M2ziA130_provenance.
- NP721031.RAUOu7B58T7JZNpGRVhfwFKJ6VANPz6NTK17WMQ3M2ziA130_assertion SIO_000772 10487842 NP721031.RAUOu7B58T7JZNpGRVhfwFKJ6VANPz6NTK17WMQ3M2ziA130_provenance.
- NP721031.RAUOu7B58T7JZNpGRVhfwFKJ6VANPz6NTK17WMQ3M2ziA130_assertion wasDerivedFrom befree-20150227 NP721031.RAUOu7B58T7JZNpGRVhfwFKJ6VANPz6NTK17WMQ3M2ziA130_provenance.
- NP721031.RAUOu7B58T7JZNpGRVhfwFKJ6VANPz6NTK17WMQ3M2ziA130_assertion wasGeneratedBy ECO_0000203 NP721031.RAUOu7B58T7JZNpGRVhfwFKJ6VANPz6NTK17WMQ3M2ziA130_provenance.